Rchr
J-GLOBAL ID：200901002522571998
Update date: Jun. 08, 2020
Horiba Mitsuru
ホリバ ミツル | Horiba Mitsuru
Research field (1)：
Cardiology
Research theme for competitive and other funds (4)：
2002 - 不整脈治療に関する研究
2000 - 血管新生の解析と治療への応用
2000 - 心筋障害のメカニズム解明とその予防
1999 - 動脈硬化予防に関する研究
MISC (24)：
Hiroharu Takenaka, Mitsuru Horiba, Hisaaki Ishiguro, Arihiro Sumida, Mayumi Hojo, Akihiko Usui, Toshiaki Akita, Sadatoshi Sakuma, Yuichi Ueda, Itsuo Kodama, et al. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2009. 296. 2. H462-H469
Hiroharu Takenaka, Mitsuru Horiba, Hisaaki Ishiguro, Arihiro Sumida, Mayumi Hojo, Akihiko Usui, Toshiaki Akita, Sadatoshi Sakuma, Yuichi Ueda, Itsuo Kodama, et al. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2009. 296. 2. H462-H469
Mitsuru Horiba, Takao Muto, Norihiro Ueda, Tobias Opthof, Keiko Miwa, Mayurni Hojo, Jong-Kook Lee, Kaichiro Kamiya, Itsuo Kodama, Kenji Yasui. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. LIFE SCIENCES. 2008. 82. 11-12. 554-560
Mitsuru Horiba, Takao Muto, Norihiro Ueda, Tobias Opthof, Keiko Miwa, Mayurni Hojo, Jong-Kook Lee, Kaichiro Kamiya, Itsuo Kodama, Kenji Yasui. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. LIFE SCIENCES. 2008. 82. 11-12. 554-560
Takao Muto, Norihiro Ueda, Tobias Opthof, Tomoko Ohkusa, Kohzo Nagata, Shinsuke Suzuki, Yukiomi Tsuji, Mitsuru Horiba, Jong-Kook Lee, Haruo Honjo, et al. Aldosterone modulates I-f current through gene expression in cultured neonatal rat ventricular myocytes. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2007. 293. 5. H2710-H2718
ｍore...
Patents (4)：
Pharmaceutical Compositions for the Prevention and Treatment of Atherosclerosis and Restenosis after PTCA
Composition for treating or preventing myocardial disorder or heart failure
Pharmaceutical Compositions for the Prevention and Treatment of Atherosclerosis and Restenosis after PTCA
Composition for treating or preventing myocardial disorder or heart failure
Works (11)：
重症閉塞性末梢動脈疾患に対するミッドカイン(MK)補充血管新生治療法の開発
2007 -
心臓血管新生・心筋再生のためのインジェクションカテーテル
2006 - 2006
虚血性心筋傷害(急性・慢性)に対するミッドカイン(MK)の保護作用
2005 - 2006
病態心における心筋イオンチャネルリモデリング発生の細胞内シグナル機構
2005 - 2006
循環器分野における成長因子ミッドカインの応用に関する研究
2005 - 2006
ｍore...
Professional career (1)：
医学博士
Work history (1)：
Nagoya University Research Institute of Environmental Medicine, Division Endowed Research, Research Institute of Environmental Medicine Endowed Chair Endowed Chair Accociate Professor
Awards (1)：
2004 - 日本心不全学会 Young Investigators Award
Association Membership(s) (1)：
日本内科学会 日本循環器学会 日本心電学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
